Cangrelor — A Champion Lost in Translation ? New England Journal of Medicine (subscription) Current guidelines recommend the early use of drugs that block platelet adenosine diphosphate (ADP) receptor P2Y 12 in patients with acute coronary ... |
For more information, please visit
http://news.google.com/news/url?fd=R&sa=[...]CNGd31DxFprWkvQ0KMDQqDJiZWv9Qg